EVENTS
  • CACLP Announces New Date and Venue for the Highly Anticipated 2025 Event

    The 22nd China International In Vitro Diagnostic Expo by CACLP will take place 22-24 March 2025 at Hangzhou Grand Convention & Exhibition Center in Hangzhou, Zhejiang Province, China. A diverse range of concurrent academic activities will commence on 21 March, offering a comprehensive and valuable experience.

    CACLP & CISCE 2024 Draw Global Attention to Innovations and Collaborations in IVD Industry

    From 16 to 18 March 2024, the bustling halls of Chongqing International Expo Center witnessed a remarkable convergence of innovations and advancements, as the 21st China Association of Clinical Laboratory Practice Expo (CACLP) and the 4th edition of China IVD Supply Chain Expo (CISCE) concluded with resounding success.

    CACLP & CISCE 2024 Highlights: New Exhibition Area

    To enhance the overall experience for both our exhibitors and visitors, the CISCE exhibition in March 2024 will be divided into five specialized zones for Supply Chain, Consumables, General Lab Equipments, Components, and Raw Materials in addition to the CACLP show, which shall mainly present the Instruments and Reagents as well as International Pavilion.

    International Laboratory Medicine and In Vitro Diagnostics Forum

    With the rapid development of technology, in vitro diagnostics (IVD) is playing an increasingly important role in the field of medicine. The application of next-generation technologies such as molecular biology, genomics, immunology, and others has not only increased the sensitivity and specificity of diagnostics but has also made the detection, diagnosis, and monitoring of diseases more accurate, rapid, and personalized. *Simultaneous interpretation (CNH/EN) is provided onsite.​

NEWS
LAWS & REGULATIONS
PARTNERS
CAIVD WeChat
Subscription Account
CAIVD WeChat
Channels

China Association of In-vitro Diagnostics

Part of the information in our website is from the internet.

If by any chance it violates your rights, please contact us.